<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="944575da-eb42-40dc-9dfe-8ee02bba38f1"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>Metronidazole<br/>Topical Cream, 0.75%<br/>
      <br/>Rx only<br/>FOR TOPICAL USE ONLY<br/>(NOT FOR OPHTHALMIC USE)</title>
   <effectiveTime value="20241031"/>
   <setId root="567c7c0c-ffc1-47c1-b0fb-8715bf3d76b9"/>
   <versionNumber value="1"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="867220261" root="1.3.6.1.4.1.519.1"/>
            <name>Mayne Pharma Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="251676961" root="1.3.6.1.4.1.519.1"/>
                        <name>G Production Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C43360" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="manufacture"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="68308-711" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="bbd4c785-2df3-41ba-a480-44e1f5e495f9"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL product data elements section"/>
               <title/>
               <text/>
               <effectiveTime value="20250416"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="68308-711" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>METRONIDAZOLE</name>
                        <formCode code="C28944" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CREAM"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>METRONIDAZOLE</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="7.5"/>
                              <denominator unit="g" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="140QMO216E" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>METRONIDAZOLE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="140QMO216E" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>METRONIDAZOLE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="LKG8494WBH" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BENZYL ALCOHOL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="PDC6A3C0OX" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>GLYCERIN</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="8CRQ2TH63M" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>ISOPROPYL PALMITATE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="506T60A25R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SORBITOL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="33X04XA5AT" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>LACTIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="g" value="45"/>
                              <denominator unit="1" value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code/>
                              <formCode code="C42794" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TUBE"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="1"/>
                                    <denominator unit="1" value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="68308-711-45" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43182" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="CARTON"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="20250519"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic classCode="OBS">
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="Type 0: Not a Combination Product" xsi:type="CE"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="20250519"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <subjectOf>
                        <approval>
                           <id extension="NDA020531" root="2.16.840.1.113883.3.150"/>
                           <code code="C73605" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="NDA authorized generic"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38304" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="TOPICAL"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
               <component>
                  <observationMedia ID="MM88925">
                     <text>carton-image</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="053216 P58248-0 Metronidazole Cream  45g carton MAYNE.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_cb6efdd5-ddf2-48b6-a314-026935ea9c22">
               <id root="017ab156-6daf-42f4-939f-1b2954801a18"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION:</title>
               <text>
                  <paragraph>Metronidazole Topical Cream contains metronidazole, USP, at a concentration of 7.5 mg per gram (0.75%) in an emollient cream consisting of benzyl alcohol, emulsifying wax, glycerin, isopropyl palmitate, purified water, sorbitol solution, lactic acid and/or sodium hydroxide to adjust pH. Metronidazole is a member of the imidazole class of antibacterial agents and is classified therapeutically as an antiprotozoal and antibacterial agent. Chemically, metronidazole is 2-methyl-5-nitro-1<content styleCode="italics">H</content>- imidazole-1-ethanol. The molecular formula is C<sub>6</sub>H<sub>9</sub>N<sub>3</sub>O<sub>3</sub> and molecular weight is 171.16. Metronidazole is represented by the following structural formula:</paragraph>
                  <paragraph>
                     <renderMultiMedia referencedObject="SPLSERV-9e89328a-c453-4b82-8d5d-f1fadd32b1b1"/>
                  </paragraph>
               </text>
               <effectiveTime value="20160524"/>
               <component>
                  <observationMedia ID="SPLSERV-9e89328a-c453-4b82-8d5d-f1fadd32b1b1">
                     <text>metro-crm-chem-struct</text>
                     <value mediaType="image/jpeg" xsi:type="ED">
                        <reference value="metro-crm-chem-struct.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_40aed112-95fe-410c-b35d-f0a2b833ba3f">
               <id root="05bf65d7-5672-45a7-9246-01a468596897"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY:</title>
               <text>
                  <paragraph>The mechanisms by which metronidazole acts in the treatment of rosacea are unknown, but appear to include an anti-inflammatory effect.</paragraph>
               </text>
               <effectiveTime value="20160524"/>
            </section>
         </component>
         <component>
            <section ID="ID_ea86e0a5-3d70-429c-bd68-c554a7d3f753">
               <id root="d2561765-7634-4a6e-a1ae-441fbe5e7704"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE:</title>
               <text>
                  <paragraph>Metronidazole Topical Cream is indicated for topical application in the treatment of inflammatory papules and pustules of rosacea.</paragraph>
               </text>
               <effectiveTime value="20160524"/>
            </section>
         </component>
         <component>
            <section ID="ID_bbde80bb-e490-4f65-a3ff-c0e4214a470a">
               <id root="f1f99b92-7ea0-48ca-892b-37d33b34bfa4"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS:</title>
               <text>
                  <paragraph>Metronidazole Topical Cream is contraindicated in individuals with a history of hypersensitivity to metronidazole, or other ingredients of the formulation.</paragraph>
               </text>
               <effectiveTime value="20160524"/>
            </section>
         </component>
         <component>
            <section ID="ID_d60df68e-1a22-4b5b-863b-ff2060ba3b9f">
               <id root="5d06cffd-079c-4a2f-91b3-99a7354bc6e0"/>
               <code code="42232-9" codeSystem="2.16.840.1.113883.6.1" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS:</title>
               <text/>
               <effectiveTime value="20160524"/>
               <component>
                  <section ID="ID_d3e102fd-d5cf-4dfc-bb69-e446465b39bd">
                     <id root="fed19a5c-5c15-4d28-8b38-02234deba5cd"/>
                     <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>General:</title>
                     <text>
                        <paragraph>Topical metronidazole has been reported to cause tearing of the eyes. Therefore, contact with the eyes should be avoided. If a reaction suggesting local irritation occurs, patients should be directed to use the medication less frequently or discontinue use. Metronidazole is a nitroimidazole and should be used with care in patients with evidence of, or history of blood dyscrasia.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_9f2112df-fa5d-4f87-a013-20df4342b18f">
                     <id root="cdbf9307-52f9-4572-8c29-8450ab74ee75"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>Information for patients:</title>
                     <text>
                        <paragraph>This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_2acee82a-a9c3-4914-a9a3-50599102571b">
                     <id root="0a10a566-66b8-4552-964a-ea023f6fe909"/>
                     <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
                     <title>Drug Interactions:</title>
                     <text>
                        <paragraph>Oral metronidazole has been reported to potentiate the anticoagulant effect of warfarin and coumarin anticoagulants, resulting in a prolongation of prothrombin time. The effect of topical metronidazole on prothrombin time is not known.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_705459a2-9b7f-4fc3-bfa6-b63238f89249">
                     <id root="f8e618c2-5b94-489a-8d4e-d754ce3565cd"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, mutagenesis, impairment of fertility:</title>
                     <text>
                        <paragraph>Metronidazole has shown evidence of carcinogenic activity in a number of studies involving chronic, oral administration in mice and rats but not in studies involving hamsters.</paragraph>
                        <paragraph>Metronidazole has shown evidence of mutagenic activity in several <content styleCode="italics">in vitro</content> bacterial assay systems. In addition, a dose-response increase in the frequency of micronuclei was observed in mice after intraperitoneal injections and an increase in chromosome aberrations have been reported in patients with Crohn's disease who were treated with 200-1200 mg/day of metronidazole for 1 to 24 months. However, no excess chromosomal aberrations in circulating human lymphocytes have been observed in patients treated for 8 months.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_c38e9737-5feb-41d3-bcec-e9288a854386">
                     <id root="34ca92fa-8cbc-4652-adce-b4540dfd40a8"/>
                     <code code="42228-7" codeSystem="2.16.840.1.113883.6.1" displayName="PREGNANCY SECTION"/>
                     <title>Pregnancy:</title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Teratogenic effects: Pregnancy category B:</content> There are no adequate and well-controlled studies with the use of Metronidazole Topical Cream in pregnant women. Metronidazole crosses the placental barrier and enters the fetal circulation rapidly. No fetotoxicity was observed after oral metronidazole in rats or mice. However, because animal reproduction studies are not always predictive of human response and since oral metronidazole has been shown to be a carcinogen in some rodents, this drug should be used during pregnancy only if clearly needed.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_fd30e26d-4538-4723-a432-e2a896500868">
                     <id root="fb2b5df5-c344-4d26-9480-93b8873a5283"/>
                     <code code="34080-2" codeSystem="2.16.840.1.113883.6.1" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing mothers:</title>
                     <text>
                        <paragraph>After oral administration, metronidazole is secreted in breast milk in concentrations similar to those found in the plasma. Even though blood levels are significantly lower with topically applied metronidazole than those achieved after oral administration of metronidazole, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
               <component>
                  <section ID="ID_4ce9b1f9-6bf4-4f5e-ad77-202ae03c5a3c">
                     <id root="d0be7169-0d57-443f-a3c2-388169e151cd"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric use:</title>
                     <text>
                        <paragraph>Safety and effectiveness in pediatric patients have not been established.</paragraph>
                     </text>
                     <effectiveTime value="20160524"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="ID_3ab4842d-1890-4cd4-89a6-8875256d6a14">
               <id root="bf31de8e-21d7-4ad4-a172-24566b548536"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS:</title>
               <text>
                  <paragraph>In controlled clinical trials, the total incidence of adverse reactions associated with the use of Metronidazole Topical Cream was approximately 10%. Skin discomfort (burning and stinging) was the most frequently reported event followed by erythema, skin irritation, pruritus and worsening of rosacea. All individual events occurred in less than 3% of patients. The following additional adverse experiences have been reported with the topical use of metronidazole: dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea.</paragraph>
               </text>
               <effectiveTime value="20160524"/>
            </section>
         </component>
         <component>
            <section ID="ID_c40912af-f4a1-4ffc-ab68-5552002646b0">
               <id root="5efe2eaf-2165-4120-9bfd-13ef94d5bdbf"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION:</title>
               <text>
                  <paragraph>Apply and rub in a thin layer of Metronidazole Topical Cream twice daily, morning and evening, to entire affected areas after washing. Areas to be treated should be washed with a mild cleanser before application. Patients may use cosmetics after application of Metronidazole Topical Cream.</paragraph>
               </text>
               <effectiveTime value="20160524"/>
            </section>
         </component>
         <component>
            <section ID="ID_e804ac16-986f-4f72-84d9-cb669d5d179b">
               <id root="6c54d12d-b288-4eda-8ce2-be649534674b"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED:</title>
               <text>
                  <paragraph>Metronidazole Topical Cream, 0.75% is supplied in a 45 g aluminum tube -<content styleCode="bold">NDC </content>68308<content styleCode="bold">-711-</content>45<content styleCode="bold">.</content>
                  </paragraph>
                  <paragraph>
                     <br/>Storage conditions: STORE AT CONTROLLED ROOM TEMPERATURE, 68° TO 77°F (20° TO 25°C), EXCURSIONS PERMITTED BETWEEN 59° AND 86°F (15° TO 30°C).</paragraph>
                  <paragraph/>
                  <paragraph>DIstributed by:<br/>
                     <content styleCode="bold">Mayne Pharma</content>
                     <br/>Raleigh, NC 27609<br/>1-844-825-8500<br/>
                     <br/>Product of Canada<br/>
                     <br/>P58249-0<br/>Revised: 10/2024</paragraph>
               </text>
               <effectiveTime value="20250103"/>
            </section>
         </component>
         <component>
            <section ID="ID_65a9a98e-b160-485f-bab7-4c5a3c9eccf6">
               <id root="7bba3aae-9542-47a4-acfa-5f82591660d7"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Package Label</title>
               <text>
                  <renderMultiMedia referencedObject="MM88925"/>
                  <paragraph/>
                  <paragraph>NDC 68308-<content styleCode="bold">711</content>-45</paragraph>
                  <paragraph>
                     <content styleCode="bold">Metronidazole Topical Cream<br/> 0.75%</content>
                     <br/>
                     <br/>Rx Only<br/>Net Wt. 45 g<br/>
                     <br/>maynepharma</paragraph>
                  <paragraph>Product of Canada<br/>
                     <br/>Distributed by:<br/>
                     <content styleCode="bold">Mayne Pharma</content>
                     <br/>Raleigh, NC 27609<br/>
                     <br/>Rev. 10/2024<br/>P58248-0</paragraph>
                  <paragraph>
                     <content styleCode="bold">FOR TOPICAL USE ONLY. NOT FOR OPHTHALMIC USE.</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">STORE AT CONTROLLED ROOM TEMPERATURE, 68° TO 77°F (20° TO 25°C), <br/>EXCURSIONS PERMITTED BETWEEN 59° AND 86°F (15° TO 30°C).</content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">Usual dosage:</content> Apply a thin layer to entire affected areas after washing. Use morning and evening or as directed by physician. Avoid application close to the eyes.</paragraph>
                  <paragraph>
                     <content styleCode="bold">Each gram contains: Active:</content> metronidazole 0.75% (7.5 mg).</paragraph>
                  <paragraph>
                     <content styleCode="bold">Inactive:</content> benzyl alcohol, emulsifying wax, glycerin, isopropyl palmitate, purified water, sorbitol solution, lactic acid and/or sodium hydroxide to adjust pH.</paragraph>
                  <paragraph>See crimp end for lot number and expiration date.</paragraph>
               </text>
               <effectiveTime value="20250103"/>
            </section>
         </component>
      </structuredBody>
   </component>
</document>